Epidemiology of Glioblastoma Multiforme-Literature Review

Cancers (Basel). 2022 May 13;14(10):2412. doi: 10.3390/cancers14102412.

Abstract

Glioblastoma multiforme (GBM) is one of the most aggressive malignancies, with a median overall survival of approximately 15 months. In this review, we analyze the pathogenesis of GBM, as well as epidemiological data, by age, gender, and tumor location. The data indicate that GBM is the higher-grade primary brain tumor and is significantly more common in men. The risk of being diagnosed with glioma increases with age, and median survival remains low, despite medical advances. In addition, it is difficult to determine clearly how GBM is influenced by stimulants, certain medications (e.g., NSAIDs), cell phone use, and exposure to heavy metals.

Keywords: brain tumor; central nervous system; epidemiology; glioblastoma multiforme; protective factor; risk factor.

Publication types

  • Review

Grants and funding

This study was supported by the statutory budget of the Department of Biochemistry and Medical Chemistry of Pomeranian Medical University in Szczecin, Poland.